Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.

Batra J, Soares AS, Mehner C, Radisky ES.

PLoS One. 2013 Sep 20;8(9):e75836. doi: 10.1371/journal.pone.0075836.

2.

Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.

Batra J, Robinson J, Soares AS, Fields AP, Radisky DC, Radisky ES.

J Biol Chem. 2012 May 4;287(19):15935-46. doi: 10.1074/jbc.M112.341156.

3.

Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2.

Maskos K, Lang R, Tschesche H, Bode W.

J Mol Biol. 2007 Mar 2;366(4):1222-31.

PMID:
17196980
4.

Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.

Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K.

EMBO J. 1998 Sep 1;17(17):5238-48.

5.

Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.

Hamze AB, Wei S, Bahudhanapati H, Kota S, Acharya KR, Brew K.

Protein Sci. 2007 Sep;16(9):1905-13.

6.

Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).

Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.

Biochem J. 2003 Jun 15;372(Pt 3):799-809.

7.

Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.

Remacle AG, Shiryaev SA, Radichev IA, Rozanov DV, Stec B, Strongin AY.

J Biol Chem. 2011 Jun 10;286(23):21002-12. doi: 10.1074/jbc.M110.200139.

9.
11.
12.

Insights into MMP-TIMP interactions.

Bode W, Fernandez-Catalan C, Grams F, Gomis-Rüth FX, Nagase H, Tschesche H, Maskos K.

Ann N Y Acad Sci. 1999 Jun 30;878:73-91. Review.

PMID:
10415721
13.

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.

Takei I, Takagi M, Santavirta S, Ida H, Hamasaki M, Ishii M, Fukushima S, Ogino T, Konttinen YT.

J Biomed Mater Res. 1999 Jun 5;45(3):175-83.

PMID:
10397973
14.

Characterization of the AB loop region of TIMP-2. Involvement in pro-MMP-2 activation.

Rapti M, Knaüper V, Murphy G, Williamson RA.

J Biol Chem. 2006 Aug 18;281(33):23386-94.

15.

Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.

Morgunova E, Tuuttila A, Bergmann U, Tryggvason K.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7414-9.

16.
17.
18.
20.

MMP-TIMP interaction depends on residue 2 in TIMP-4.

Stratmann B, Farr M, Tschesche H.

FEBS Lett. 2001 Nov 2;507(3):285-7.

Items per page

Supplemental Content

Support Center